Radiation Oncology
Academic Department
Faculty Research Areas
Affiliation
organization within
Research
administers grant
- A Digital Twin for rectal cancer to guide adaptive radiotherapy
- A Prospective Comparative Study of Outcomes with Proton and Photon Radiation in Prostate Cancer" ("COMPPARE")
- Biochemical and functional characterization of a novel anti-inflammatory biogenic amine
- CD4 and CD8 T cell epitopes recognized in autoimmune and autoinflammatory diseases
- Cancer Cell Intrinsic Interferon-I pathway Activation by Fractionated Radiation
- Converting HR+ Breast Cancer Into an Individualized Vaccine
- Converting HR+ Breast Cancer Into an Individualized Vaccine
- Creating a 3D TNBC model of PTEN deficiency to discover immunoregulatory tumor epitopes
- Dynamics of Immune Response in Irradiated Rectal Cancer
- Effects of Glycation and Carbonylation on MHC II-restricted immunity
- Extending the survival of HR+ breast cancer patients receiving CDK4/6 inhibitors by targeting IL17-producing gamma delta T cells
- Fatty acid metabolic regulation of anti-tumor immunity against irradiated glioblastoma
- Functional Consequences of Impaired Autophagy in Aging - P01AG031782
- Harnessing Innate Immunity and Radiotherapy for Next-Generation Immuno-Oncology in Metastatic Breast Cancer
- Langerhans cells and lymphatic regulation in immunity
- Lymphatic drainage dysfunction in chronic hypertension
- Lymphatics-Glymphatics in CNS Fluid Homeostasis
- Optimization of immune checkpoint inhibition during radiation-induced vaccination in breast cancer
- Precision use of radiation for in situ cancer immunization
- Role of FAP-positive cells in immune response to irradiated glioblastoma
- Role of oxidative post-translational modifications in generating neoepitopes
- Targeting fatty acid synthesis to restore anti-tumor immunity against irradiated glioblastoma
- Targeting the BCL2 immune checkpoint to enhance the immunostimulatory effects of radiation in breast cancer
- Therapeutic targeting of breast cancer and host immune responses at inflection points in the disease trajectory